Kura Oncology, Inc. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Kura Oncology, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q2 2024.
  • Kura Oncology, Inc. Operating Lease, Payments for the quarter ending June 30, 2024 was $500K, a 16.7% decline year-over-year.
  • Kura Oncology, Inc. annual Operating Lease, Payments for 2023 was $2.1M, a 8.7% decline from 2022.
  • Kura Oncology, Inc. annual Operating Lease, Payments for 2022 was $2.3M, a 9.52% increase from 2021.
  • Kura Oncology, Inc. annual Operating Lease, Payments for 2021 was $2.1M, a 600% increase from 2020.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $500K -$100K -16.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $500K -$100K -16.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q2 2023 $600K $0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $600K $0 0% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q2 2022 $600K +$100K +20% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $600K +$100K +20% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q2 2021 $500K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $500K +$300K +150% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q1 2020 $200K +$100K +100% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q1 2019 $100K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.